Literature DB >> 25755495

Hepatobiliary quiz-6 (2013).

Swastik Agrawal1, Radha K Dhiman1.   

Abstract

Entities:  

Year:  2013        PMID： 25755495      PMCID： PMC3940316          DOI： 10.1016/j.jceh.2013.05.006

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  75 in total

1.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

2.  Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding.

Authors:  S Mahadeva; M C Bellamy; D Kessel; M H Davies; C E Millson
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

3.  Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries.

Authors:  B Brandsaeter; S Friman; U Broomé; H Isoniemi; M Olausson; L Bäckman; B Hansen; E Schrumpf; A Oksanen; B G Ericzon; K Höckerstedt; H Mäkisalo; P Kirkegaard; K Bjøro
Journal:  Scand J Gastroenterol       Date:  2003-11       Impact factor: 2.423

4.  Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis.

Authors:  Jacob George; Natasha Pera; Nghi Phung; Isabelle Leclercq; Jing Yun Hou; Geoffrey Farrell
Journal:  J Hepatol       Date:  2003-11       Impact factor: 25.083

5.  Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma.

Authors:  Spiros G Delis; Andreas Bakoyiannis; Ioannis Biliatis; Konstantinos Athanassiou; Nikos Tassopoulos; Christos Dervenis
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

6.  Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.

Authors:  Gennaro D'Amico; Roberto De Franchis
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

Review 7.  Nonalcoholic fatty liver disease and liver transplantation.

Authors:  Paul Angulo
Journal:  Liver Transpl       Date:  2006-04       Impact factor: 5.799

8.  High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.

Authors:  Susan N Cullen; Christian Rust; Kenneth Fleming; Cathryn Edwards; Ulrich Beuers; Roger W Chapman
Journal:  J Hepatol       Date:  2008-02-14       Impact factor: 25.083

9.  Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.

Authors:  G R Sarma; C Immanuel; S Kailasam; A S Narayana; P Venkatesan
Journal:  Am Rev Respir Dis       Date:  1986-06

10.  Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

Authors:  Christian E Oberkofler; Philipp Dutkowski; Reto Stocker; Reto A Schuepbach; John F Stover; Pierre-Alain Clavien; Markus Béchir
Journal:  Crit Care       Date:  2010-06-15       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.